Next Article in Journal
Regulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance
Next Article in Special Issue
Common Altered Epigenomic Domains in Cancer Cells: Characterization and Subtle Variations
Previous Article in Journal / Special Issue
Role of Gene Methylation in Antitumor Immune Response: Implication for Tumor Progression
Open AccessArticle

Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy

1
Department of Cellular and Structural Biology, UTHSCSA, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
2
Department of Obstetrics and Gynecology, UTHSCSA, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
*
Author to whom correspondence should be addressed.
Cancers 2011, 3(2), 1691-1707; https://doi.org/10.3390/cancers3021691
Received: 4 January 2011 / Revised: 11 March 2011 / Accepted: 25 March 2011 / Published: 29 March 2011
(This article belongs to the Special Issue Epigenetics of Cancer Progression)
Estrogen receptor (ERa) signaling plays a key role in hormonal cancer progression. ERa is a ligand-dependent transcription factor that modulates gene transcription via recruitment to the target gene chromatin. Emerging evidence suggests that ERa signaling has the potential to contribute to epigenetic changes. Estrogen stimulation is shown to induce several histone modifications at the ERα target gene promoters including acetylation, phosphorylation and methylation via dynamic interactions with histone modifying enzymes. Deregulation of enzymes involved in the ERa-mediated epigenetic pathway could play a vital role in ERa driven neoplastic processes. Unlike genetic alterations, epigenetic changes are reversible, and hence offer novel therapeutic opportunities to reverse ERa driven epigenetic changes. In this review, we summarize current knowledge on mechanisms by which ERa signaling potentiates epigenetic changes in cancer cells via histone modifications. View Full-Text
Keywords: estrogen receptor; histone modifications; epigenetics; breast cancer; hormonal cancers estrogen receptor; histone modifications; epigenetics; breast cancer; hormonal cancers
Show Figures

Graphical abstract

MDPI and ACS Style

Mann, M.; Cortez, V.; Vadlamudi, R.K. Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy. Cancers 2011, 3, 1691-1707.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop